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Metabolic syndrome is a growing public health concern. Efforts at searching for links
with the gut microbiome have revealed that propionate is a major fermentation product
in the gut with several health benefits toward energy homeostasis. For instance,
propionate stimulates satiety-inducing hormones, leading to lower energy intake and
reducing weight gain and associated risk factors. In (disease) scenarios where microbial
dysbiosis is apparent, gut microbial production of propionate may be decreased.
Here, we investigated the effect of a propionogenic bacterial consortium composed
of Lactobacillus plantarum, Bacteroides thetaiotaomicron, Ruminococcus obeum,
Coprococcus catus, Bacteroides vulgatus, Akkermansia muciniphila, and Veillonella
parvula for its potential to restore in vitro propionate concentrations upon antibiotic-
induced microbial dysbiosis. Using the mucosal simulator of the human intestinal
microbial ecosystem (M-SHIME), we challenged the simulated colon microbiome
with clindamycin. Addition of the propionogenic consortium resulted in successful
colonization and subsequent restoration of propionate levels, while a positive effect
on the mitochondrial membrane potential (19m) was observed in comparison with
the controls. Our results support the development and application of next generation
probiotics, which are composed of multiple bacterial strains with diverse functionality
and phylogenetic background.
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INTRODUCTION
The human gut plays a major role in nutrition, metabolism, pathogen resistance, and regulation
of immune response (Dethlefsen et al., 2008; Turroni et al., 2012). Microbial fermentation
processes in the gut leading to production of short chain fatty acids (SCFA), are the result of
metabolic interactions between different gut species (Dethlefsen et al., 2008). The main SCFA
(acetate, propionate, and butyrate) (McOrist et al., 2008) perform important physiological functions
(Hosseini et al., 2011), occur in molar ratio of 3:1:1 in the colon (Hosseini et al., 2011) and are
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used by the microbiota for growth and maintenance of cellular
functions in the host (Fernandes et al., 2014). Acetate is absorbed
and transported to the liver for cholesterol and fatty acid synthesis
in the host, playing major role in enhancing ileal motility
(Hosseini et al., 2011), while butyrate is the key energy source
for colonocytes. Butyrate prevents proliferation of cancerous cells
and stimulates differentiation of colon epithelial cells (Hosseini
et al., 2011). The health effects of propionate go beyond the
gut epithelium, as it lowers serum cholesterol levels, lipogenesis,
and carcinogenesis risk (Fernandes et al., 2014). Propionate may
also decrease obesity by promoting the secretion of PYY and
GLP-1 hormones from human colonic cells (Tolhurst et al.,
2011; Chambers et al., 2014; Psichas et al., 2014; Morrison
and Preston, 2016), inducing satiety and subsequently reducing
energy intake and promoting weight loss (Arora et al., 2011).
Propionate is a particularly interesting metabolite in the context
of the etiology and progress of metabolic syndrome, which is
becoming a public health issue. Metabolic syndrome is defined
as a cluster of different biological factors characterized by obesity,
dyslipidemia, and type 2 diabetes (Halcox and Quyyumi, 2005;
Alberti et al., 2009; Moore et al., 2017; Nolan et al., 2017). This
syndrome is linked to different comorbidities like cardiovascular
disease, non-alcoholic fatty liver, arthritis, chronic kidney disease,
and several types of cancers (Halcox and Quyyumi, 2005;
Dugas et al., 2016; Moore et al., 2017). Recent studies have
reported an association between gut microbiota and metabolic
syndrome, as the gut composition differs between healthy and
diseased individuals. The gut microbiota is responsible for
producing different regulatory peptide hormones (Silva and
Bloom, 2012), depending on the nutrient supply provided, as
their interaction with receptors at different points in the gut-
brain axis leads to satiety (Silva and Bloom, 2012). Propionate
has been reported to have the highest affinity for the free
fatty acid receptor 2 (FFAR 2), involved in the regulation of
metabolic homeostasis. In fact, long-term propionate delivery in
the gut stimulates anorexigenic gut hormones, reducing intra-
abdominal fat accretion, intrahepatocellular lipid content, and
hepatic cholesterol synthesis in humans (Arora et al., 2011;
Chambers et al., 2014). In addition, propionate is involved in
activation of intestinal gluconeogenesis (IGN), thus regulating
food intake and enhancing insulin sensitivity (Li et al., 2017).
As propionate production is associated with gut microbiome
composition and functionality, different modulators such as
antibiotics, prebiotics, and probiotics (El Hage et al., 2017)
can impact this metabolite. Antibiotics may foster pathogenic
opportunistic bacteria (Francino, 2016), influencing human
health (Jin et al., 2016). Long-term antibiotic use can lead to
increased body mass index and weight gain in both humans
and farm animals (Francino, 2016), alter transcription of genes
involved in liver lipid metabolism (Jin et al., 2016), increase
insulin resistance, and steatosis in patients with fatty liver
(Miquilena-Colina et al., 2011). Antibiotic use has also been
reported to cause bacterial translocation, which may represent an
additional inflammatory stimulus potentially promoting obesity
(Knoop et al., 2015). Hence, antibiotic use is considered a
risk factor for metabolic disorders (Economopoulos et al.,
2016; Francino, 2016). For instance, the Cl− molecule present
in the clindamycin disrupts the mitochondrial membrane
potential (Goldhill et al., 1996); similar disruption has been
reported following oxidative damage in metabolic syndrome
(Nicolson, 2007). Thus, we applied clindamycin as an agent
to simulate the conditions of oxidative stress occurring during
metabolic syndrome.
Synthetic microbial communities have been proposed to
prevent and treat disease and reverse gut dysbiosis more
effectively than single strain approaches (El Hage et al., 2017).
Because of its beneficial effects on the host metabolism,
propionate in our gut could contribute to solve the metabolic
syndrome puzzle. We therefore aimed at engineering a
propionate-producing synthetic microbial community, with
functional redundancy on the different metabolic pathways
for propionate production (acrylate, succinate, propanediol)
(Reichardt et al., 2014). We then evaluated its potential to restore
gut functionality after antibiotic-associated dysbiosis, using the
Simulator of the Human Intestinal Microbial Ecosystem
(SHIME). Knowledge regarding successful engraftment
of functional communities can be applied for developing
preventative novel probiotic strategies to ameliorate microbiome
imbalances associated with metabolic syndrome.
MATERIALS AND METHODS
Selection of Strains for the
Propionate-Producing Consortium (PPC)
Gut commensal strains were selected based on the reported
metabolic pathways for propionate production (succinate,
acrylate, and propanediol pathways) (Reichardt et al., 2014;
Table 1). Veillonella parvula, Bacteroides vulgatus, and
Bacteroides thetaiotaomicron were reported to take the succinate
pathway in which they use succinate to produce propionate
(Louis et al., 2014). Coprococcus catus has been reported to
take the acrylate pathway for propionate production, in which
lactate is consumed (Louis et al., 2014). To provide lactate for
Coprococcus catus, we supplied the consortium with Lactobacillus
plantarum, a lactic acid bacterium, producing lactate and acetate
that can support the acrylate pathway. Ruminococcus obeum
uses the propanediol pathway (Louis et al., 2014) fermenting
fucose for propionate production. Fucose can be produced
from mucin degradation, and as Akkermansia muciniphila is
a mucin-degrader producing propionate, this bacterium was
used to enrich the propanediol pathway. The single strains
produced between 0.4 and 3 mM of propionate, and the
final propionate for the consortium was 34.5 mM on average
(Supplementary Figure 4).
Assembly of Propionate-Producing
Community
Culturing of bacteria was performed in Reinforced
Clostridium Medium (Oxoid Ltd., Basingstoke, Hampshire,
United Kingdom), using the Hungate tube method and under
anaerobic conditions (90% N2/10% CO2). All strains were
incubated at 37◦C for 48 h except for L. plantarum, which
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TABLE 1 | Bacterial strains used to prepare the propionate-producing consortium
according to the different metabolic pathways for propionate production (Acrylate,
Succinate, Propanediol).
Bacterial species Source
Bacteroides vulgates LMG17767
Bacteroides thetaiotaomicron DSM 2079
Coprococcus catus ATCC 27761
Veillonella parvula DSM 2007
Ruminococcus obeum (Blautia) DSM 25238
Akkermansia muciniphila DSM 22959
Lactobacillus plantarum LMG 9211
For Acrylate pathway, Lactobacillus plantarum and Coprococcus catus were
selected; for succinate pathway, Bacteroides vulgatus, Veillonella parvula, and
Bacteroides thetaiotaomicron were selected, and for propanediol pathway,
Akkermansia muciniphila and Ruminococcus obeum were selected.
was incubated for 24 h. At the end of the incubation, cell
count was measured using flow cytometry, and standardized to
108 cells ml−1.
Following, the consortium was subjected to the environmental
conditions of the colon. Thus, the consortium culturing medium
(L-SHIME medium, Prodigest NV, Zwijnaarde, Belgium) was
subjected to pre-digestion simulating the passage through the
upper GI tract. Gastric digestion was mimicked by maintaining
pH 2 for 2 h, followed by addition of pancreatic juice [(0.9 g
L−1 pancreatin (Sigma-Aldrich, St. Louis, MO, United States), 6 g
L−1 Oxgall (BD, Erembodegem, Belgium), and 25 g L−1 NaHCO3
(Carl Roth GmbH, Karlsruhe, Germany)]. pH was adjusted to 6.8,
and medium was incubated for 2.5 h at 37◦C to simulate the small
intestine digestion. pH was adjusted to 6.8 prior addition of the
bacterial cocktail.
Then, 5 ml of each strain were mixed under anaerobic
conditions. The consortium was prepared by transferring 5 ml
of the bacterial cocktail (10% v/v) to an anaerobic glass
bottle containing 45 ml of pre-digested medium. Co-culture
occurred for 48 h, and 40% of the medium was replaced after
24 h. The consortium was harvested after 48 h, when the
average propionate concentration was 34.5 mM (Supplementary
Figure 4). The viable cell count of the consortium was 108 cells
ml−1 when administered to the M-SHIME.
Dynamic Simulation of the Colon
Environment
The mucosal simulator of the human intestinal microbial
ecosystem (M-SHIME) is an in vitro model including both
mucosal and luminal microbiota and simulating the digestive
processes in the human intestinal tract (Van den Abbeele et al.,
2012). We initially applied the model to evaluate the impact of
a single dose of the consortium, in comparison with repeated
doses, in separate SHIME runs. The experiments using single vs.
repeated doses were performed using fresh fecal material from
one female (27 yo), and one male donor (29 yo). Validation of
the repeated dosing required fecal samples from six more donors
of the same age group (30 ± 5). All donors were healthy with a
normal BMI and did not use antibiotics for the last 6 months.
The M-SHIME setup consisted of double-jacketed reactors
representing the stomach, small intestine and colon (Truchado
et al., 2017). We simulated the environment of the transverse
colon and thus, the pH was between 6.3 and 6.5, and the volume
was 660 mL calculated upon retention time. Nutritional medium
composition was described previously (Truchado et al., 2017),
and each colon vessel had a mucosal environment consisting of
80 mucin agar-covered microcosms (AnoxKaldnes K1 carrier;
AnoxKaldnes AB, Lund, Sweden), placed in a polyethylene
netting (Zakkencentrale, Rotterdam, The Netherlands) (Van den
Abbeele et al., 2012). Each M-SHIME vessel was inoculated with
8% (w/v) fecal slurry (Molly et al., 1993; Possemiers et al., 2004).
Static incubation was completed for the first 16 h, to allow for
initial stabilization of the system. After 16 h, the peristaltic pumps
were started up to supply each colon vessel with 200 mL of
pre-digested feed three times per day every 8 h. Pre-digestion
consisted of a 45 min incubation in the stomach-small intestine
compartment. All reactors were flushed with N2 to ensure
anaerobic conditions. A scheme of the M-SHIME is presented in
Supplementary Material (Supplementary Figure 5).
After 10 days of stabilization, 33.9 mg L−1 of clindamycin
(Sigma-Aldrich, St. Louis, Mo, United States) were added to all
colon vessels twice per day for 3 days, to trigger dysbiosis. Four
days after the last antibiotic treatment, a single dose (45 ml,
6.8% of volume) of the propionate-producing consortium (PPC)
was added to triplicate treatment vessels, while the other three
reactors were kept as controls. Three days after the single dose,
three consecutive doses of the treatment were added again for
three consecutive days. The system was monitored for further
4 days to investigate the further effect of the consortium. The
whole experiment ran for 27 days in case of the first 2 donors
and 23 days for the six donors. Samples for VFA analysis and for
DNA extraction were collected every day before the first medium
replacement. Samples were collected from the M-SHIME every
day and analyzed for SCFA. Samples that were sent for Illumina
sequencing were samples from different days that present the
end of the different phases of the SHIME run. Lumen samples
were collected at days 11, 17, 20, and 23 representing stabilization
phase, antibiotic treatment phase, PPC treatment phase and
washout phase, respectively. The mucin samples were collected
less frequently since mucin beads were changed every other day,
so the samples collected were at days 9, 14, and 21 presenting
stabilization phase, antibiotic treatment phase, and after PPC
treatment phase, respectively.
Single vs. Multiple Donor Experiment
In single donor experiment, the SHIME reactors were inoculated
with the fecal sample of one human donor having 3 replicates for
control condition and 3 replicates for treatment condition. Single
donor experiments were run to ensure technical reproducibility
of our experimental setup. For further validation of the results
from the single donor experiments, multiple donor experiment
was run using fecal inoculum from six different human donors. In
the multiple donor experiment, the SHIME included 12 reactors
representing colon vessels. Each 2 reactors were inoculated
with a fecal sample from one single donor representing one
control reactor and one treatment. Samples for SCFA and
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DNA analysis were collected everyday from each reactor and
analyzed separately. The results from SCFA analysis and illumina
sequencing were pooled together for statistical analysis.
Community Functionality and
Composition
SCFAs Extraction
Short-chain fatty acids were used as benchmarks of community
activity, and were collected from the luminal compartment, and
extracted with diethyl ether (De Weirdt et al., 2017). Total SCFA
production was defined as the sum of the molar concentrations
of acetate, propionate, butyrate, valerate, caproate, isobutyrate,
isovalerate and isocaproate (De Weirdt et al., 2017). Differences
in VFA concentrations among treatments were compared using
a repeated measures mixed model, with the lsmeans adjustment
and Sidak correction for multiple comparisons (GraphPad Prism
7.04, La Jolla, CA, United States). Statistical significance was
assumed at P < 0.05.
DNA Extraction and Illumina Library Generation
Total DNA from luminal and mucosal samples was extracted
using physical disruption with the bead beating method
(Hernandez-Sanabria et al., 2010). Briefly, samples were thawed,
manually homogenized, and centrifuged at 14,600 × g for 5 min
at 4◦C. The pellet was resuspended in 1 ml of lysis buffer
(100 mM Tris pH8, 100 mM Na EDTA pH8, 100 mM NaCl,
1% (w/v) polyvinylpyrrolidone, 1% PVP40, and 2% (w/v) sodium
dodecyl sulfate) and transferred to a 2 ml microcentrifuge tube
containing 0.3 g of zirconium beads (diameter, 0.1 mm). The
cells were lysed in a Power Lyzer 24 (Mo Bio Laboratories,
Carlsbad, CA, United States) for 3 min at 4800 rpm. DNA
concentration and quality were verified based on the absorbance
at 260 and 280 nm, using a DeNovix DS (Thermo Fisher
Scientific, Waltham, MA, United States).
The V3–V4 hypervariable region of the 16S rRNA gene was
amplified using primers 341F and 785R. Illumina sequencing
adapters and dual-index barcodes were added to the amplicon,
using a limited-cycle PCR that included an initial denaturation
step at 95◦C for 3 min, 15 cycles of a denaturation step at 95◦C
for 30 s, an annealing step at 55◦C for 10 s, an extension step at
72◦C for 45 s, and a final extension at 72◦C for 5 min. Following,
a clean-up step was performed using the AMPure XP beads
(Beckman-Coulter, Krefeld, Germany) to remove free primers
and primer-dimer species from amplicons. A second PCR to
attach the specific Illumina multiplexing sequencing primers
and index primers, was performed. Thermal cycling included
an initial denaturation step at 95◦C for 3 min, 8 cycles of a
denaturation step at 95◦C for 30 s, an annealing step at 55◦C for
30 s, an extension step at 72◦C for 30 s, and a final extension at
72◦C for 5 min.
These PCR products were verified by gel electrophoresis,
purified using the Promega Wizard PCR clean-up kit (Promega,
Madison, WI, United States) following the manufacturer’s
instructions and quantified with the QuantiFluor dsDNA System
kit (Promega, Leiden, The Netherlands). High-throughput
amplicon sequencing of the V3–V4 hypervariable region
(Klindworth et al., 2013) was performed with the Illumina MiSeq
platform according to the manufacturer’s guidelines at LGC
Genomics GmbH (Berlin, Germany). Contigs were created by
merging paired-end reads based on the Phred quality score (of
both reads) heuristic as described by Kozich et al. (2013) in
Mothur (Schloss et al., 2009) (v.1.33.3). Contigs were aligned to
the SILVA database and filtered from those with (i) ambiguous
bases, (ii) more than 10 homopolymers, and (iii) those not
corresponding to the V3–V4 region.
Chimera removal and operational taxonomic unit (OTU)
clustering of the sequencing reads was performed using
UCHIME, with the nearest neighbor clustering algorithm
implemented in mothur, at 0.03 distance (Edgar, 2010). Phylotype
representatives were then generated by clustering at 97%
similarity (1 mismatch), with a confidence level of at least 80
with Cyanobacteria, Eukaryota, and Archaea lineages removed.
For taxonomic classification, sequence composition of the dataset
was compared using the RDP Classifier tool (Wang et al., 2007),
and the RDP trainset (Cole et al., 2009) version 9. Quality of
the sequencing and post-processing pipeline was verified by
incorporating mock samples (n = 12 species) in triplicate into the
same sequencing run. After examining read counts, if any OTU
was not classified up to genus level, the consensus sequence was
blasted using the SILVA database (Pruesse et al., 2012) to obtain
the taxonomic classification. In addition, all OTU sequences were
aligned with those obtained from the sequencing of the 16S rRNA
genes of each species, using Clustal Omega1.
Community Composition and Dynamics
Data was imported into R using phyloseq (McMurdie and
Holmes, 2013), and taxon abundances were rescaled by
calculating the taxon proportions and multiplying them by the
minimum sample size (n = 24789) present in the data set
(McMurdie and Holmes, 2014). Alpha diversity was initially
estimated within each sample using Richness, Fisher’s diversity,
Shannon, Simpson, and inverse Simpson indices. Inverse
Simpson was the metric used for final assessment. Pielou
index was used as indicator of evenness in the community
(Grunert et al., 2016). Differences in alpha diversity and evenness
measures among treatments were compared using a repeated
measures mixed model in SAS, using the lsmeans adjustments
and Bonferroni correction for multiple comparisons (version
9.4, SAS Institute, Cary, NC, United States). To confirm
these results, comparisons between control and treatment were
performed using a 2-way Anova (Sidak’s method) and between
and within time points using Tukey’s method in GraphPad
(GraphPad Prism 7.04, La Jolla, CA, United States) (Figure 3 and
Supplementary Tables 3, 4).
Beta diversity estimates based on Chao and Bray-Curtis
indices were used to examine dissimilarity and determine the
impact of treatment and time on microbial community structure.
Principal Coordinate Analysis (PCoA) was employed to visualize
the differences among samples, using the vegan package in R
(Oksanen et al., 2007) (Supplementary Figure 7). Stratified
permutational multivariate analysis of variance (PERMANOVA)
with 999 permutations was conducted to indicate the significance
1http://www.ebi.ac.uk/Tools/msa/clustalo/
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of time and treatment on the microbial community differences.
ANOVA was applied to reveal whether the distribution of the
genera was different between treatments over time (Oksanen
et al., 2007). Because of the over-dispersion in the OTU counts
data, a zero-inflated count model was used to assess the effect of
time and treatment and the interactions between time∗treatment
on each individual genus. Zero-inflated models explain the
excess of zeros by modeling the data as a mixture of a Poisson
distribution or a negative binomial distribution. When a zero
count is observed there is the zero-inflation probability, because
the observation came from the always-zero distribution. When
the underlying count distribution is a Poisson distribution, the
model is called a zero-inflated Poisson distribution and if the
count distribution is a negative binomial distribution, the mixture
is called a zero-inflated negative binomial distribution. The final
model was selected based on the Akaike Information Criterion
(AIC). Differences among library size sample were accounted for
with the offset option in proc GLIMMIX in SAS (Paschold et al.,
2012). P-values for each comparison were converted to q-values
that were then used to identify differences in relative abundances
of bacterial genera while controlling false discovery rate (FDR) at
the 5% level (Storey and Tibshirani, 2003).
Bipartite networks were inferred to highlight functional
associations among bacterial genera and metabolites, using
a pair-wise similarity matrix obtained from a Regularized
Canonical Correlation Analysis (Lê Cao et al., 2011). Values
of the similarity matrix were computed as the correlation
between the relative abundances of bacterial genera and the
metabolic variables, projected onto the space spanned by the first
components retained in the analysis. Three relevant components
were obtained setting a threshold of r ≥ 0.7 and genera were
disseminated in the plot, in close relation with the variables
correlated (De Weirdt et al., 2017).
Enumeration of Microbial Cells Using
Flow Cytometry
To assess variation in cell counts in lumen and mucin
compartments, we analyzed SHIME samples collected at
different time points from different phases of the SHIME run
(stabilization phase, after antibiotic phase, after treatment phase
and washout phase).
Cell Counts From Lumen and Mucin Samples
Samples used for cell counts were frozen at -20◦C. All samples
were diluted 1:1 in filter-sterilized PBS, and vortexed for 1 min
at maximum speed. Mucin samples were disrupted for 40 s at
1800 rpm (Power Lyser 24, MO BIO Laboratories, Carlsbad,
CA, United States), and centrifuged at 500 × g for 4 min,
while lumen samples were centrifuged at 500 × g for 2 min.
Supernatants were collected and passed through 20 µm filters
(Filcon, BD Medimachine, Erembodegem, Belgium) to remove
particulate matter. Filtered samples were then diluted 5000 times
in filter-sterilized PBS, and 198 µl of the diluted sample was
stained with 2 µl of SYBR Green (SG) (10,000 × diluted
from stock; Invitrogen, Carlsbad, CA, United States) in 96 flat-
bottom well plate. The plate with the stained samples was
incubated for 20 min at 37◦C. Flow cytometric analysis of the
microbial cells present in the suspension was performed using a
C6 plus Accuri flow cytometer (BD Biosciences, Erembodegem,
Belgium) equipped with a 488 nm laser, following previously
described methods (Props et al., 2017). Fluorescence events
were monitored using the FL1 533/30 nm and FL3 > 670 nm
optical detectors. Forward and sideways-scattered light was also
collected. The BD Accuri CSampler software was used to gate
and separate the microbial fluorescence events on the SSC-A
and FITC-A density plot from the lumen and mucin SHIME
sample background. Gating was evaluated using a 0.2 µm filter.
A threshold value of 1,000 was applied on the FL1 channel. The
gated fluorescence events were evaluated on the SSC-FL1 density
plot, to exclude remaining background events and to obtain an
accurate microbial cell count. Instrument and gating settings
were kept identical for all samples.
For quantification of absolute numbers of each taxon, samples
were rescaled by multiplying the relative abundance of each genus
by the flow cytometry cell counts.
Assessment of the Mitochondrial
Membrane Potential
Propionate promotes flux of Cl− to the mucosa, increasing
the short-circuit current, hence stimulating colonic contractions
through a change in potential difference (Yajima, 1988). As
reduced intestinal motility and low-grade inflammation are
markers of metabolic syndrome (Müller et al., 2018), we assessed
the capability of the PPC to change the mitochondrial membrane
potential (19m). We used an in vitro model of the gut epithelium
to reveal whether the supplementation of the consortium could
potentially restore disrupted membrane potential, as observed
in metabolic syndrome. Caco-2 cells were seeded onto opaque
clear bottom 96-well plates (Corning, NY, United States) at a
density of 20,000 cells/well and maintained for 72 h. Then,
cell culture media was removed, and cells were exposed to the
treatments in Table 2.
All the compounds were diluted from the stock solution
in DMSO to the corresponding working solution in DMEM
without supplementation. Filter-sterilized consortium was
TABLE 2 | Treatments added to epithelial cell model to assess changes on
membrane potential.
Treatment Concentration Time
Clindamycin hydrochloride 33.9 mg/L 24 h
Filter-sterilized PPC (1:5 v/v in DMEM) 2:1 Acetate:Propionate ratio 24 h
CLN + PPC 33.9 mg/L + P/A/B 24 h
Cell culture medium (negative control) – 24 h
CCCP (positive control for disrupted 19m) 50 µM 2 h
DMSO (control for CCCP vehicle) <0.01% 2 h
A negative control was used in which the cells did not get any treatment or
disruption. CCCP was used as a positive control for disruption of membrane
potential. The metabolites from the propionate-producing consortium (PPC) were
added above the cells after being filter-sterilized. To assess the ability of the
consortium (PPC) to restore the disruption caused by clindamycin (CLN), its
metabolites were added together with clindamycin above the epithelial cells. P/A/B,
propionate/acetate/butyrate mixture at the ratios produced by the consortium
(Supplementary Figure 4).
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diluted 1:5 (v/v) in DMEM without supplementation. DMSO
was used as a control.
After exposing the cells to the treatments for 24 h at 37◦C
(95% humidity, 10% CO2), cells were washed once with 200 µl
of PBS with Ca++ and Mg++ (Sigma) and 100 µl of JC-1 stain
(10 µM in DMEM) (Cayman Chemical, MI, United States) were
added to the wells and incubated for 20 min. Following, wells
were washed with PBS supplied with Ca++ and Mg++ and 10%
FBS, and 100 µl of DMEM were added to each well before
measuring with a SpectraMax Plus Microplate Reader (Molecular
Devices, LLC). Excitation/emission wavelength pairs were set at
475/530 nm and 475/590 nm, for JC-1 monomer and aggregate
detection, respectively. The background (A590 of non-stained
cells) was subtracted from the test signals. Results were expressed
as the ratio between aggregate/monomer. All Pairwise Multiple
Comparison Procedures and Statistical analysis was done using
Holm-Sidak method in GraphPad (GraphPad Prism 7.04, La
Jolla, CA, United States).
RESULTS
We assessed the reproducibility of the simulated clindamycin-
induced dysbiosis using the Mucosal Simulator of the Human
Intestinal Ecosystem (M-SHIME), before evaluating the
potential of the PPC to restore functionality. Two M-SHIME
runs were separately conducted with fecal microbiota from
two volunteers, and treatments were supplied to triplicate
reactors. Concentrations and profiles of SCFA in the luminal
content of the proximal colon compartments across the three
technical replicate reactors were found to be reproducible
(Supplementary Figures 1, 2).
Gut Microbiome Functionality Is
Improved When a Propionate-Producing
Consortium Is Supplied After Antibiotic
Use in Donor 1
Altered production of SCFA is considered one of the hallmarks
of dysbiosis, and thus, we validated that clindamycin disrupted
the fermentation pattern of the simulated gut ecosystem.
Upon antibiotic supplementation, propionate and butyrate
decreased by approximately 57 and 95%, respectively, and
remained consistently and significantly low (P < 0.05) across all
triplicate experiments for both donors 1 and 2 (Supplementary
Figures 1, 2). In the single donor experiments, we found
that one single dose of the PPC did not promote functional
recovery on either of the donors (Supplementary Figures 1, 2),
whereas three consecutive doses of the consortium triggered a
significant increase in propionate production only in donor 1
(14.84 ± 1.06 mM; P < 0.05, Supplementary Figure 1). This
positive outcome remained consistent across the three replicates
until the end of the experiment (Supplementary Figure 1 and
Supplementary Table 1). As the impact of one single dose
of the consortium seemed to be marginal, we decided to use
three consecutive doses in a multiple-donor experiment. We
conducted an extra M-SHIME run with fecal samples from six
different donors of the same age group (30 ± 5 yo). Functional
recovery and inter-individual variability were assessed, and
all the following results presented were from the multiple-
donor experiment.
Modulation of Microbiota Functionality
by a Propionate-Producing Consortium
Upon Antibiotic Induced Dysbiosis
After disruption with clindamycin, there was a significant and
consistent decrease in butyrate, propionate, and acetate by 88,
46, and 16%, respectively (P < 0.05) (Figure 1). Inter-individual
differences in SCFA production were observed upon dosing the
PPC. Repeated supplementation of the consortium promoted
significant increase in propionate production (12.47 ± 0.88 mM;
P< 0.05), compared with the control (7.57± 0.37 mM), resulting
in nearly 100% recovery of the initial propionate concentrations.
Restoration of butyrate and acetate was variable across the
six different donors and no significant recovery was observed
(Figure 1). These observations confirm that our designed
microbial consortium led to effective functional recovery of
propionate production following dysbiosis.
Propionate-Producing Consortium
Supports the Partial Recovery of the
Epithelial Mitochondrial Membrane
Potential After Antibiotic Disruption
Mitochondrial membrane potential of epithelial cells is
fundamental for gut motility as well as for cell division,
as it modulates the distribution of several conserved cell
division proteins (Strahl and Hamoen, 2010). Carbonyl cyanide
m-chlorophenylhydrazone (CCCP) was used as a positive control
for the disruption of the membrane potential, because it rapidly
disperses the proton motive force (pmf) or membrane potential
(Strahl and Hamoen, 2010). A significant decrease in membrane
potential was observed when CCCP without consortium was
added to our cell model, confirming the negative effect of the
CCCP on the membrane potential (Supplementary Table 2,
P < 0.05, Figure 2). Clindamycin decreased the membrane
potential by approximately 80% (P < 0.05), confirming the
negative effect of the antibiotic toward epithelial cells. When
clindamycin was added together with the PPC, the ratio of the
aggregate monomer of the JC1 was increased by 40% (P < 0.05),
indicating partial recovery of the membrane potential after
clindamycin disruption.
Antibiotic Use Significantly Decreased
the Bacterial Cell Load
A workflow for the quantitative microbiome profiling can
be built through parallelization of amplicon sequencing and
flow cytometric enumeration of microbial cells (Vandeputte
et al., 2017). Flow cytometry revealed a significant decrease
in the cell count after antibiotic use in both lumen and
mucin compartments (P < 0.05). Administration of the PPC
did not impact the total cell load (P > 0.05). However, cell
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FIGURE 1 | Addition of the propionate-producing consortium (PPC) promotes recovery of propionate production after antibiotic-associated disruption. CTR: Control,
TRT: Treatment, AB: Antibiotic. (A) Short chain fatty acid production during the three different phases of the experiment: Stabilization, post-antibiotic disruption, and
post-addition of the propionate-producing consortium. Antibiotic treatment was added on days 11, 12, and 13. Treatment was added on days 17, 18, and 19. Days
in which antibiotics and PPC were added were indicated by arrows. (B) Propionate was the main short chain fatty acid impacted after 2 doses, as propionate levels
significantly increased from day 19 in the treatment reactors (P < 0.05). No significant difference was detected for acetate (C) and butyrate (D) after the treatment
was added. ∗∗P < 0.001.
FIGURE 2 | Propionate-producing consortium triggered a partial recovery for the membrane potential after clindamycin disruption. Following clindamycin (CLN)
supplementation, membrane potential was significantly higher when one dose of the propionate-producing consortium (PPC) was provided, in comparison with
exposure to clindamycin alone (P < 0.05). Protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) was used as a negative control to disrupt membrane
potential. All Pairwise Multiple Comparisons between treatments were assessed using Holm-Sidak method with overall significance level equal to 0.05. Significant
differences were indicated using different superscripts. Presence of the same letter in the superscript indicates that samples were not significantly different (P > 0.05).
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FIGURE 3 | Propionate-producing consortium triggered an increase of total number of species after the washout period only in the lumen compartment. Relative
abundance was quantified at the end of stabilization phase, antibiotic treatment phase, propionate-producing consortium phase, and washout phase. No effect of
the consortium on the alpha diversity of lumen (A) and the mucin (D) were detected. Antibiotic supplementation triggered significant decrease in the total number of
species (P < 0.05) only in the lumen compartment (B), but not in mucin compartment (E). The propionate-producing consortium significantly increased the total
number of species at the end of the washout (B). No effect of the consortium on the evenness of the community in the lumen (C) and the mucin (F) was observed.
count decreased in the reactors that were not supplemented
(Supplementary Figure 6).
Propionate-Producing Consortium
Shaped the Bacterial Community Based
on Number of Doses and Host Influence
As shifts in bacterial taxa and decrease in community diversity
are benchmarks of dysbiosis, we dynamically monitored both
luminal and mucosal communities using the M-SHIME.
Alpha diversity was unchanged in control and treatment
reactors in the multi-donor experiment upon consortium
supplementation (Figure 3A).
Clindamycin significantly decreased richness in all luminal
compartments (Figure 3B and Supplementary Table 3), but
consecutive doses of the PPC triggered a significant recovery of
this metric in the lumen compartment (P < 0.05). The difference
in richness between the control and treatment was not significant
until the end of the washout period, when the treatment
reactors had significantly higher total number of species than
the control reactors (P < 0.05, Figure 3B and Supplementary
Table 3). Total number of species tended to be higher in the
mucin compartment as well. As the mucosal communities are
in close contact with the host, successful function transfer in
the mucosal compartment may be relevant for possible host
effects (Figure 3E and Supplementary Table 4). In addition,
evenness of mucosal communities following antibiotic-induced
dysbiosis tended to be lower in comparison with that at the
end of the stabilization period (Figure 3F and Supplementary
Table 4). In contrast, evenness in the lumen community after
dysbiosis remained constant, suggesting that mucus bacteria
are more sensitive to antibiotics than bacteria in the lumen
environment (Figure 3C and Supplementary Table 3). We
observed that antibiotic supplementation promoted both loss
of bacterial richness and increased relative abundance of
Enterobacteriaceae and Escherichia-Shigella, albeit not significant
for the latter in the mucin (Figure 4 and Supplementary
Table 5D). Importantly, relative abundance of Escherichia-
Shigella was significantly decreased in the lumen when the
consortium was supplied (Supplementary Table 5C). Pathologies
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characterized by microbial dysbiosis have in common a decrease
in the community composition complexity, as well as an increase
in aero-tolerant genera such as Enterobacteriaceae (Vonaesch
et al., 2018). Although microbial community can be deeply
disrupted upon antibiotic use, our results indicate that the
PPC shaped the community based on the number of treatment
doses and donor.
Repeated doses of the consortium confirmed a potential
recovery of the community, both through direct engraftment and
through indirect reinforcement of other propionate producers.
For instance, unclassified Lachnospiraceae, Akkermansia
and Bacteroides increased their relative abundance in
both compartments, indicating that some members of our
consortium (Coprococcus catus, Akkermansia muciniphila,
Bacteroides thetaiotaomicron, and B. vulgatus) may have been
successfully engrafted in the mucin compartment (Figure 4
and Supplementary Table 5B). Moreover, the presence of these
genera even after the washout may suggest that indirect positive
reinforcement of the overall community may have ensued.
Long-lasting increased relative abundance of Akkermansia
species seem to be consistent across individuals, as indicated by
the community composition at the end of the washout period
(Figure 4). Moreover, the relative abundance of other species,
such as Veillonella (Supplementary Table 5A), indicate that the
intra-individual engraftment and indirect reinforcement of the
consortium may be enduring.
Addition of the Propionate-Producing
Consortium Amends Community
Metabolic Networks Following
Environmental Disruption
Relevance networks analyses indicated that SCFA-
production networks shifted with antibiotic treatment. As
metabolic products were significantly decreased when the
environmental disruption happened, larger networks including
bacteria associated with acetate production were observed
(Supplementary Figure 3A). Increased acetate concentrations
seemed to correlate with increased relative abundances
of Bifidobacterium, Faecalibacterium, Flavonifractor, and
Anaerotruncus (Supplementary Figure 3A and Supplementary
Table 5C). With respect to butyrate, a positive association was
only found with increased relative abundance of Bacteroides. No
genera were significantly associated with high concentrations
of propionate, after antibiotic was provided (Supplementary
Figure 3A) (P < 0.05).
The relevance network for the control reactors displayed
intermingled propionate and butyrate networks (Figure 5B).
This may suggest that the community competes for the substrate
available, preventing from significantly increasing propionate
production. Upon repeated dosage of the consortium, the
propionate network showed that higher relative abundances
of Unclassified Lactobacillaceae, Morganella, Hungatella,
FIGURE 4 | Relative bacterial abundances on the luminal and mucosal compartments shifted among end of stabilization, after antibiotic use, after 3 doses of PPC
and after washout. Genera with the highest relative abundances across time points were uncovered in the (A) lumen compartment and (B) mucosal compartment.
Six replicates (donors) were averaged to highlight the inter-individual effect of the propionate-producing consortium.
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FIGURE 5 | Continued
Frontiers in Microbiology | www.frontiersin.org 10 May 2019 | Volume 10 | Article 1206
fmicb-10-01206 May 29, 2019 Time: 19:35 # 11
El Hage et al. Propionate-Producing Consortium Restores Dysbiosis
FIGURE 5 | Bacterial interactions networks influenced the production of the major short chain fatty acids over time. (A) Treatment reactors at day 20 after adding 3
doses of the propionate consortium, (B) Control vessels at day 20. These bipartite networks are based on the regularized canonical correlations between relative
bacterial abundances and relative concentrations of the main SCFA. Interactions have been filtered for an absolute correlation above 0.8 and are colored following
the key shown. Significant interactions are shorter lines, and genera with similar abundances within SHIME compartment tend to cluster closely.
Erysipelatoclostridium, Unclassified Lachnospiraceae and
Bilophila were associated with higher concentrations of
propionate (Figure 5A and Supplementary Table 5C). The
increased relative abundance of these and other genera such as
Parabacteroides in the mucin (succinate producer) may confirm
the indirect positive reinforcement of the PPC on the overall
community (Supplementary Table 5C). Moreover, Hungatella
has been reported to thrive on medium used to produce probiotic
bacteria (Kaur et al., 2013).
Finally, the enduring indirect impact of the consortium
was validated on the propionate network at the end of the
washout period (Supplementary Figure 3B). We observed
that higher relative abundance of Unclassified Lactobacillaceae
was positively associated with increased concentrations of
propionate (P < 0.05), potentially revealing that acetate-
producing bacteria belonging to this family (Lactobacillus sp.)
actively participate in the functional recovery of the community.
The lasting effect of the consortium may as well indicate
the successful engraftment of one of the genera comprised
in this community. Higher abundances of Akkermansia were
associated with higher concentrations of acetate at the end of the
washout (Supplementary Figure 3B). This could be an additional
indicator of the successful adaptation and operational efficacy
of the consortium.
Variations in Cell Densities Confirmed
the Impact of the Propionate-Producing
Consortium in the Compositional
Dynamics of the Community
We performed absolute quantification of the taxa detected in
our study, to comprehensively explain the differences observed
in the relative abundances. Our results confirmed the direct
engraftment of one of the members of our consortium, as
the absolute abundance of Veillonella significantly increased
in both luminal and mucosal compartments of the treatment
reactors after providing 3 doses of the consortium (P < 0.05)
(Figure 6 and Supplementary Tables 6, 7). As for the
indirect reinforcement, relevance networks initially suggested
that some genera were linked to propionate production. We
observed a significant increase in absolute abundance of
unclassified Lactobacillaceae after adding the 3 doses of the
consortium in both lumen and mucin (P < 0.05) (Figure 7
and Supplementary Tables 8, 9). Moreover, unclassified
Lachnospiraceae significantly increased in the treatment vessels
after the washout period in the lumen compartment (P < 0.05)
(Figure 7 and Supplementary Table 8). Although Bilophila
showed increased relative abundance after adding the 3 doses of
the consortium, absolute abundance was not increased (Figure 7
and Supplementary Tables 8, 9). The combined approach of
relative and absolute abundances assisted to elucidate the course
of action of the PPC. Thus, the observed positive effect of
the consortium may be explained as a synergic impact on the
cell counts and on the relative abundances of taxa involved in
propionate production pathways.
DISCUSSION
In our study, we aimed at engineering our PPC considering the
three major pathways for propionate production (acrylate,
succinate, and propanediol pathways) (Reichardt et al.,
2014). The consortium positively impacted functionality
and composition of the microbial community and
supported the partial recovery of membrane potential after
clindamycin disruption.
SCFA analysis from the luminal SHIME samples revealed a
significant drop in bacterial metabolic activity after clindamycin-
induced dysbiosis. Previous studies reported the ability of
antibiotics to significantly influence taxonomic richness, diversity
and evenness (Dethlefsen et al., 2008; Dethlefsen and Relman,
2011; Francino, 2016; Rojo et al., 2017), as observed in the lumen
and mucosal communities of our experiment. In addition, flow
cytometry analysis confirmed the negative the effect of dysbiosis
on bacterial cell counts, as they significantly decreased upon
antibiotic administration. In the single donor experiment, one
single dose of the PPC did not impact neither functionality
measured by SCFA production nor microbial community. The
dose we provided may have not been enough for a beneficial
effect, as in the case of probiotic strategies that can only
confer a positive effect when administered in adequate amounts
(Ouwehand, 2017). Repeated doses of our consortium showed a
significant effect on the functionality in one of the 2 donors of
the single-donor experiments, and in all six samples from six
individual donors in the multiple-donor experiment, with full
recovery of propionate production. Resident bacteria potentially
interacted with the supplied PPC, as those administered may have
provided metabolites like acetate, lactate, and propionate. Thus,
resident bacteria cross-feeding on these metabolites eventually
led to the production of propionate (Derrien and van Hylckama
Vlieg, 2015). Our results suggest that restoration of propionate
production by our engineered consortium was successful.
Despite the positive impact of the PPC, some elements of
dysbiosis remained unchanged. For instance, the consistent
relative abundance of Proteobacteria like Escherichia-Shigella
and Bilophila before and after treatment, indicates that those
bacteria can act as opportunistic pathobionts in cases of dysbiosis.
Bilophila may have utilized mucin-degradation products from
our consortium to produce propionate. The positive correlation
between Bilophila and propionate may be an indicator of
the inflammatory status of the environment (Feng et al.,
2017). However, absolute abundance of this genus was not
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FIGURE 6 | Absolute abundance of the seven genera included in the propionate-producing consortium. Quantification of absolute abundances revealed the direct
engraftment of specific genera in the lumen (A) and mucin (B) compartments. Veillonella showed a significant increase (P < 0.05) in both lumen and mucin
compartments after the administration of the propionate-producing consortium.
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FIGURE 7 | Continued
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FIGURE 7 | Absolute abundance of genera involved propionate production upon consortium supplementation. Quantification of absolute abundance validated the
indirect reinforcement of specific genera in the lumen (A) and mucin (B) compartments. Lactobacillaceae was significantly increased in both lumen and mucin
compartments (P < 0.05) upon administration of the propionate-producing consortium. Lachnospiraceae showed a significant increase only in the lumen
compartment at the end of the washout phase (P < 0.05).
increased when the consortium was provided. Instead, members
from our PPC like Bacteroides and Akkermansia may have
occupied the niche of primary carbohydrate degradation and
subsequently promoted fermentation by resident bacteria, as
is the case for mucin metabolism. Mucin degradation can
liberate sugars, amino acids, sialic acids, and sulfate that can be
consumed as substrates by the resident commensals (Derrien
and van Hylckama Vlieg, 2015) or even by the provided
bacteria. Our consortium contained a strain of Akkermansia
muciniphila, a specialized mucin-degrading bacterium (Chia
et al., 2018), which could have provided sugar monomers from
mucin upon degradation. Mucin-derived sugars like fucose
could be utilized by Akkermansia muciniphila (Ottman et al.,
2017) or by Ruminococcus obeum (Lachnospiraceae) to produce
propionate through the propanediol pathway (Flint et al., 2014;
Reichardt et al., 2014). This could explain the increase in the
relative abundance in Akkermansia and Lachnospiraceae after
administering the three doses of our consortium.
Ingested bacteria can impact resident communities through at
least three different mechanisms: through trophic interactions,
a direct alteration in fitness, or an indirect alteration in
fitness through altered production of host-derived molecules
(Derrien and van Hylckama Vlieg, 2015). One of the markers
considered for successful colonization from bio-therapeutics is
engraftment (Smillie et al., 2018). Engraftment originally refers
to “incorporation of grafted tissue into the body of the host”
(Miller et al., 2005), and it has been applied to explain the
stable establishment of a bacterial strain in the human gut
(Maldonado-Gómez et al., 2016). In our SHIME model, the
complexity of the simulated colonic ecosystem allowed for
analysing the impact of the administered bacterial community
on microbial interaction networks, independently of host inputs.
To ensure engraftment, long-term persistence of the different
species of the live microbes in the consortium should be
monitored in different donors, as described by Maldonado-
Gómez et al. (2016). The beads coated with mucin in our
model provided a comprehensive overview of the bacterial
colonization process. For instance, we observed an increase
in the relative abundance of unclassified Lachnospiraceae,
Akkermansia, and Bacteroides in the mucosal compartment,
after repeated doses. This indicated that some members of
the consortium (Akkermansia muciniphila, Coprococcus catus,
Ruminococcus obeum, and Bacteroides thetaiotaomicron and
Bacteroides vulgatus) may have been successfully engrafted in
the mucin compartment. In our experiment, we attained long-
lasting increased relative abundance of Akkermansia species
across individuals, as indicated by the community composition
at the end of the washout period. Previous reports suggest
that species traits such as functionality are major drivers of
bacterial colonization (Smillie et al., 2018). In this way, the
functional redundancy of our consortium may have ensured
prevalence in the lumen following repeated dosage, even after
4 days. Akkermansia is considered a common member of the
autochthonous human gut microbiome, which may guarantee
permanent colonization as opposed to commercial probiotics
belonging to lactic-acid producing bacteria (Maldonado-Gómez
et al., 2016). Nevertheless, whether higher engraftment success
is a general attribute of autochthonous members of the
microbiome, or whether it is specific for certain probiotic strains
needs to be elucidated (Maldonado-Gómez et al., 2016).
Metabolic syndrome leads to excess cellular oxidative
stress and oxidative damage of mitochondrial components,
impacting mitochondrial membrane potential (Nicolson, 2007).
Clindamycin is a chlorinated analog of lincomycin and inhibits
basal epithelial transport (Goldhill et al., 1996), impacting
electrical field stimulation (EFS) (Goldhill et al., 1996) and
mitochondrial membrane potential (Goldhill et al., 1996). In
our epithelial cell model, the presence of a Cl− in the molecule
of the drug reduced the basal short circuit current (Goldhill
et al., 1996) and disrupted the mitochondrial membrane potential
upon exposure to clindamycin. Proper mitochondrial membrane
potential is a requirement for oxidative phosphorylation
(Mitchell, 1966; Nicolson, 2007) and impaired mitochondrial
oxidative phosphorylation contributes to the development of the
metabolic syndrome (Ren et al., 2010). Hence, the partial recovery
of the membrane potential following the addition of the PPC
suggests that application of our functional community may be
a promising strategy to amend microbial dysbiosis and confer
beneficial effects toward host epithelium.
Nowadays, next-generation probiotics and live
biotherapeutics are being developed based on core members
of the microbiome (Olle, 2013), as in the case of our
PPC. Endogenous core bacterial strains included in these
biotherapeutics may have higher ecological fitness when
administered to humans compared to the exogenous strains,
such as commercial probiotics. However, the concept of
ecological performance related to probiotic functionality is yet
to be elucidated (Maldonado-Gómez et al., 2016). In conclusion,
members of our gut microbiome can be used as new generation
probiotics for targeting different health aspects. We confirmed
that the established PPC can impact functionality by restoring the
propionate production after antibiotic-induced dysbiosis. The
key question would be if the PPC can impact beyond the ecology
of the gut microbiome and influence host health. Importantly,
as such consortia are to be administered orally, developing
carrier matrices to ensure survival to the harsh conditions of the
upper GI tract should be earnestly considered. Further research
to determine dose-response outcome and long-term benefits
will foster our knowledge on novel probiotic consortia. Indeed,
understanding strain selection and the metabolic pathways
for producing different SCFA will aid in the development of
functional consortia targeted for prevention and management of
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major health concerns, such as metabolic syndrome, or even for
personalized nutrition strategies.
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